Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Setmelanotide (Imcivree) and semaglutide (Wegovy) are both medications used for weight management, but they belong to different drug classes and have distinct uses. Setmelanotide is a melanocortin agonist specifically approved for obesity due to rare genetic conditions like POMC, PCSK1, or LEPR deficiency, and Bardet-Biedl syndrome (BBS). In contrast, semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for general weight management in adults with a body mass index (BMI) of 30 kg/m² or higher, or 27 kg/m² with a weight-related condition, and in children 12 and older with a high BMI. Setmelanotide is injected daily, while semaglutide is injected weekly. Both medications can cause nausea and stomach pain, but setmelanotide may also lead to mood changes and skin darkening, whereas semaglutide can increase the risk of thyroid cancer and gallbladder issues. Setmelanotide and semaglutide are only available as brand-name medications. Semaglutide is also available under the brand names Ozempic and Rybelsus for treating Type 2 diabetes.
Imcivree (setmelanotide)
Wegovy (semaglutide)
Imcivree (setmelanotide)
Wegovy (semaglutide)
Summary of Imcivree vs. Wegovy
Summary for Melanocortin agonist
Prescription only
Imcivree (setmelanotide) is an injectable medication for adults and children with certain rare conditions. It's FDA approved for acquired hypothalamic obesity (HO). It's also approved to help with obesity caused by some genetic conditions. These are Bardet-Biedl syndrome (BBS) and POMC, PCSK1, or LEPR deficiency. The medication works as a melanocortin agonist. It lessens appetite and makes the body use more energy, leading to weight loss. It's injected under the skin once a day. Side effects include darkening of skin color and nausea. More serious risks include depression and suicidal thoughts.
Summary for GLP-1 agonist
Prescription only
Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist. It comes in prefilled pens you use to inject the medication under the skin once a week. Wegovy (semaglutide) also comes as tablets that are swallowed once a day. This medication is approved for weight loss in some people. It can help lower the risk of heart attack, stroke, and death due to heart problems in adults with a larger body size and heart disease. The pens are also approved for certain adults with a liver problem called metabolic dysfunction-associated steatohepatitis (MASH). The medication works best when taken with a lower-calorie diet and regular exercise. Side effects include nausea, diarrhea, and stomach pain.
Indications of Imcivree vs. Wegovy
Indications for
•
Weight loss and long-term weight management in people ages 4 years and older with obesity due to damage to the hypothalamus (acquired hypothalamic obesity, HO)
•
Weight loss and long-term weight management in people ages 2 years and older with obesity due to certain genetic conditions: